Last reviewed · How we verify
NCT05214300
Screening for Bleeding Disorders in Children
trial in Bleeding Disorder in 96 participants. Completed in 20 December 2021.
1 December 2021
Quick facts
| Lead sponsor | University Hospital, Montpellier |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 96 |
| Start date | 1 December 2019 |
| Primary completion | 1 December 2021 |
| Estimated completion | 20 December 2021 |
| Sites | 1 location across France |
Conditions studied
- Bleeding Disorder — all drugs for Bleeding Disorder →
Sponsor
University Hospital, Montpellier
Who can join
Under 18, any sex, with Bleeding Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators try to improve the screening of bleeding disorders in children by identifying symptoms, laboratory abnormalities and clinical scores discriminating patients congenital bleeding disorders in order to create a simple screening algorithm applicable in pediatrics, aiming for use in pre-anesthetic consultation and in consultation by pediatricians and general practitioners.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Gingival bleeding is a useful clinical feature in the diagnosis of hereditary bleeding disorders in children.
Edme E, Sola C, Cau-Diaz I, Sirvent N, et al · · 2024 · cited 1× · PMID 38386030 · DOI 10.1007/s00431-024-05487-6
Verify or expand the search:
- PubMed search for NCT05214300
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bleeding Disorder
Currently open trials in the same condition.
- NCT06736158 — Early Genomic Testing for Inherited Bleeding Disorders · EARLY_PHASE1 · recruiting
- NCT06727669 — Longitudinal Cohort of Thrombosis and Hemostasis Diseases · recruiting
- NCT06118372 — Recombinant vWF Concentrate and ECMO · Phase 1 · recruiting
- NCT06635564 — Personalized ViscoElastic Testing-guided Bleeding Management In Liver Surgery, Neurosurgery and Obstetrics · recruiting
- NCT05713734 — Bleeding of Unknown Cause: a Swiss Case-control Study · recruiting
Other University Hospital, Montpellier trials
Trials by the same sponsor.
- NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
- NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
- NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
- NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
- NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05214300 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
- Last refreshed: 28 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05214300.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing